Marimed (MRMD) Non-cash Items (2012 - 2014)

Marimed's (MRMD) quarterly Non-cash Items came in at $734900.0 in Q1 2014, up 38.66% year-on-year from $530000.0 in Q1 2013, and up 990.08% on a QoQ basis from $67417.0 in Q4 2013.

Marimed (MRMD) Non-cash Items (2012 - 2014) Analysis & Trends

Marimed (MRMD) has 3 years of Non-cash Items data on file, last reported at $734900.0 in Q1 2014.

  • On a quarterly basis, Non-cash Items rose 38.66% year-over-year to $734900.0 in Q1 2014; TTM through Mar 2014 was $888317.0, a N/A change from a year earlier, with the FY2016 full-year figure at $1.4 million, up 5.81% from the prior year.
  • Non-cash Items for Q1 2014 stood at $734900.0, up from $67417.0 in the prior quarter.
  • Over the last five years, Non-cash Items for MRMD reached as high as $734900.0 in Q1 2014 and fell as low as $37000.0 in Q3 2013.
  • Historically, Non-cash Items has averaged $248386.2 across 3 years, with a median of $69708.5 in 2012.
  • Across the five-year window, Non-cash Items sank 48.61% in 2013 and jumped 38.66% in 2014, its largest moves.
  • Year by year, Non-cash Items stood at $72000.0 in 2012, then slipped by 6.37% to $67417.0 in 2013, then surged by 990.08% to $734900.0 in 2014.
  • Per Business Quant data, the three most recent Non-cash Items figures were $734900.0 in Q1 2014, $67417.0 in Q4 2013, and $37000.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Marimed 23.85 Mn 14.02 Mn 15.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2014 734,900.00
Mar 31, 2014 734,900.00
Dec 31, 2013 67,417.00
Dec 31, 2013 67,417.00
Sep 30, 2013 37,000.00
Sep 30, 2013 37,000.00
Jun 30, 2013 49,000.00
Jun 30, 2013 49,000.00
Mar 31, 2013 530,000.00
Mar 31, 2013 530,000.00
Sep 30, 2012 72,000.00
Sep 30, 2012 72,000.00